SRPT

#1857
Sarepta Therapeutics,, Inc. Common Stock
22.26 USD
+2.16%
セクター: ヘルスケア
ベース: USD
利益通貨: USD
日中レンジ
22.11
22.44
1年のレンジ
10.41
64.80
1日の変化
+2.16%
月次変化
+34.91%
6か月変化
+2.30%
1年の変化
-58.89%
以前の終値
21.79
始値
22.21
Bid
Ask
安値
22.11
High
22.44
ボリューム
1 140
チャート全体を表示

Financials

概要 明細書 統計
期次 年次
  • Market Capitalization 2.34 B
  • Employee 835
  • Founded 1980
  • CEO Douglas S. Ingram
  • Website www.sarepta.com
  • Headquarter Delaware, United States
  • FIGI BBG000BCJ161
  • Industry Technology
総売上高
当期純利益
1株当たり基本利益（基本EPS）
有利子負債合計
フリーキャッシュフロー
現金および現金同等物
株価収益率
-3.02
売上高対価格比率
0.98

Sarepta Therapeutics Inc

Sarepta Therapeutics, Inc. is a medical research and drug development company with corporate offices and research facilities in Cambridge, Massachusetts, United States. Incorporated in 1980 as AntiVirals, shortly before going public the company changed its name from AntiVirals to AVI BioPharma soon with stock symbol AVII and in July 2012 changed name from AVI BioPharma to Sarepta Therapeutics and SRPT respectively. As of 2023, the company has four approved drugs.

ニュース